Association of Endothelial Glycocalyx Integrity with Left Ventricular Performance and Remodeling after Acute

John Thymis1, Konstantinos Katogiannis1, George Pavlidis1

  • 12nd Department of Cardiology, School of Medicine University General Hospital "Attikon," National and Kapodistrian University of Athens, Athens, Greece.

PubMed

Insights

ST elevation myocardial infarction (STEMI) patients show reduced endothelial glycocalyx integrity. This integrity, measured by perfused boundary region (PBR), predicts left ventricular performance post-STEMI, offering a new diagnostic marker.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomedical Engineering

Background:

  • ST elevation myocardial infarction (STEMI) is linked to endothelial dysfunction.
  • The integrity of the endothelial glycocalyx, a key component of endothelial function, is not well understood in STEMI patients.
  • Assessing endothelial glycocalyx may offer insights into post-STEMI cardiac performance.

Purpose of the Study:

  • To investigate if endothelial glycocalyx thickness is affected in STEMI patients.
  • To determine if endothelial glycocalyx integrity can predict left ventricular performance after STEMI.
  • To establish a potential diagnostic marker for adverse cardiac events post-STEMI.

Main Methods:

  • Examined 278 STEMI patients and 140 controls.
  • Measured sublingual microvessel perfused boundary region (PBR4-25) as an indicator of glycocalyx integrity.
  • Assessed left ventricular ejection fraction (LVEF), global longitudinal strain (LVGLS), and end-systolic volume (ΔLVESV) at baseline and 12 months.

Main Results:

  • STEMI patients exhibited significantly higher PBR4-25 values, indicating reduced glycocalyx integrity, compared to controls.
  • PBR4-25 was independently associated with LVEF and LVGLS at 48 hours post-MI.
  • PBR4-25 remained a significant predictor of LVEF, LVGLS, and ΔLVESV changes at 12-month follow-up.

Conclusions:

  • Endothelial glycocalyx integrity is compromised in STEMI patients.
  • Assessing endothelial glycocalyx thickness via PBR is associated with myocardial performance after STEMI.
  • PBR measurements may serve as a valuable prognostic tool for predicting left ventricular function post-STEMI.

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...